Abstract
There are two modern evolutionary theories of mammal senescence: Programmed theories contend that mammals purposely limit their lifespans because doing so creates an evolutionary advantage. Non-programmed theories contend that each mammal specie only needs a particular lifespan and therefore only evolved and retained the capability for attaining that lifespan. Arguments over the evolutionary nature of aging have now existed for more than 150 years and for reasons described here may never be definitively resolved.
The programmed/ non-programmed question is critical to medical research because the theories have grossly different predictions regarding the biological mechanisms associated with the aging process and therefore, the nature of age-related diseases and conditions.
This article describes and compares two approaches for avoiding the need to obtain resolution on the evolutionary basis of senescence in order to identify and characterize the biological mechanisms responsible for aging and therefore the nature of highly age-related diseases.
Keywords: Aging, ageing, senescence, gerontology, medical research policy.
Current Aging Science
Title:Is the Evolutionary Programmed/ Non-programmed Aging Argument Moot?
Volume: 8 Issue: 1
Author(s): Theodore C. Goldsmith
Affiliation:
Keywords: Aging, ageing, senescence, gerontology, medical research policy.
Abstract: There are two modern evolutionary theories of mammal senescence: Programmed theories contend that mammals purposely limit their lifespans because doing so creates an evolutionary advantage. Non-programmed theories contend that each mammal specie only needs a particular lifespan and therefore only evolved and retained the capability for attaining that lifespan. Arguments over the evolutionary nature of aging have now existed for more than 150 years and for reasons described here may never be definitively resolved.
The programmed/ non-programmed question is critical to medical research because the theories have grossly different predictions regarding the biological mechanisms associated with the aging process and therefore, the nature of age-related diseases and conditions.
This article describes and compares two approaches for avoiding the need to obtain resolution on the evolutionary basis of senescence in order to identify and characterize the biological mechanisms responsible for aging and therefore the nature of highly age-related diseases.
Export Options
About this article
Cite this article as:
Goldsmith C. Theodore, Is the Evolutionary Programmed/ Non-programmed Aging Argument Moot?, Current Aging Science 2015; 8 (1) . https://dx.doi.org/10.2174/1874609808666150422104524
DOI https://dx.doi.org/10.2174/1874609808666150422104524 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mediterranean Food Pattern in Rheumatoid Arthritis
Current Rheumatology Reviews The Relationship Between Hypertensive Retinopathy and Angiotensin Converting Enzyme Gene Polymorphism
Cardiovascular & Hematological Disorders-Drug Targets The Follow-Up of Dietary Treatment of Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Effects of Ganoderma Lucidum on Contractile Dysfunction of the Rabbit Urinary Bladder using an In-Vitro Model of Ischemia/Reperfusion
The Natural Products Journal Can Life Before Birth Affect Health Ever After?
Current Women`s Health Reviews Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets Hyperhomocysteinemia in Movement Disorders: Current Evidence and Hypotheses
Current Vascular Pharmacology Hypercholesterolemia and Endothelium Dysfunction: Role of Dietary Supplementation as Vascular Protective Agents
Current Vascular Pharmacology Structural and Functional Diversity of Estrogen Receptor Ligands
Current Topics in Medicinal Chemistry Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Current Rheumatology Reviews β2-AR-HIF-1α: A Novel Regulatory Axis for Stress-Induced Pancreatic Tumor Growth and Angiogenesis
Current Molecular Medicine Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders. Part 1: Conventional Therapy
Current Pharmaceutical Design Attenuation of Diabetes-induced Cardiac and Subcellular Defects by Sulphur-containing Amino Acids
Current Medicinal Chemistry The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Neutrophil to Lymphocyte (N/L) and Platelet to Lymphocyte (P/L) Ratios in Differentiating Acute Heart Failure from Respiratory Infection
Current Vascular Pharmacology Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design Multitarget Drugs of Plants Origin Acting on Alzheimer's Disease
Current Medicinal Chemistry Analogy of Cardiac and Renal Complications in Essential Hypertension and Aged SHR or L-NAME/SHR
Medicinal Chemistry Military Risk Factors for Cognitive Decline, Dementia and Alzheimer’s Disease
Current Alzheimer Research Editorial (Thematic Issue: Focal Atrial Tachycardias and Atrial Flutter: Are they Hot Enough to Make a Thematic Issue?)
Current Cardiology Reviews